SCHEMBL5870092

SCHEMBL5870092

CCN(C(=O)C(Cc1cnc[nH]1)NC(CC(C)C)C(=O)O)c1ccc(OC)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ ITGB2 P05107 2/20 0.41
▸ ICAM1 P05362 2/20 0.41
▸ ITGAL P20701 2/20 0.41
▸ POLB P06746 1/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ FNTA P49354 3/20 0.39
▸ FNTB P49356 3/20 0.39
▸ PGGT1B P53609 2/20 0.39
▸ S1PR1 P21453 1/20 0.38
▸ SLC6A5 Q9Y345 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ ACE2 Q9BYF1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8255250 0.79 ITGB2 (0.54) ALDH1A1CYP1A2CYP3A4CYP2C19ITGB2
SCHEMBL8255793 0.78 POLB (0.52) POLB
SCHEMBL5870074 0.78 POLB (0.52) POLB
SCHEMBL9830757 0.72 CA2 (0.67) ALDH1A1CYP1A2CYP3A4CYP2C19ITGB2
1,3,5-Trimethoxybenzene SCHEMBL27988484 0.69 ITGB2 (0.51) ALDH1A1CYP1A2CYP3A4CYP2C19ITGB2
SCHEMBL9830947 0.69 MME (0.57) ITGB2ICAM1ITGALPOLBFNTA
SCHEMBL5870452 0.69 REN (0.53) ACE2
SCHEMBL8249066 0.69 REN (0.53) ACE2
SCHEMBL16673386 0.68 ITGB2 (0.51) ALDH1A1CYP1A2CYP3A4CYP2C19ITGB2
SCHEMBL5833201 0.68 ITGB2 (0.57) ALDH1A1CYP1A2CYP3A4CYP2C19ITGB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045532-B2 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-05-16 — — US disclosed
US-6632830-B1 Blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder MILLENNIUM PHARMACEUTICALS, INC. 2003-10-14 — — US disclosed
Send feedback